MT-5199

· Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-5199, covering 2023-08-14 to 2023-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia [Phase 2, Phase 3]